Literature DB >> 11592373

Microchimerism in a female patient with systemic lupus erythematosus.

K L Johnson1, T E McAlindon, E Mulcahy, D W Bianchi.   

Abstract

Systemic lupus erythematosus (SLE) is a serious multisystem disease that has a striking propensity to affect women. The cause of SLE remains elusive. Fetomaternal cell trafficking, or the passage of fetal cells into the maternal circulation, is now a well-established phenomenon. In addition, fetal cells have been implicated in the development of preeclampsia and in the pathogenesis of scleroderma. We undertook this study to determine whether fetomaternal cell trafficking might also be involved in pathogenic processes in SLE. Fluorescence in situ hybridization analysis was performed using X and Y chromosome-specific probes on affected and unaffected tissue obtained at autopsy from a woman who had previously given birth to 2 males and who had died of complications of SLE. The goal of the analysis was to detect the presence of male cells of putative fetal origin. Male cells were found in every histologically abnormal tissue type that was examined, but were not found in histologically normal tissue. These data suggest that fetal cells may be associated with SLE. It is unclear whether their presence may be related to disease causation, an effect of disease progression, or unrelated to disease pathology. However, this case study is an important step toward understanding the potential relationship between fetomaternal cell trafficking and SLE pathology.

Entities:  

Mesh:

Year:  2001        PMID: 11592373     DOI: 10.1002/1529-0131(200109)44:9<2107::AID-ART361>3.0.CO;2-9

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  20 in total

1.  Long-term feto-maternal microchimerism: nature's hidden clue for alternative donor hematopoietic cell transplantation?

Authors:  Tatsuo Ichinohe; Etsuko Maruya; Hiroh Saji
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

Review 2.  Fetal microchimerism and maternal health during and after pregnancy.

Authors:  Keelin O'Donoghue
Journal:  Obstet Med       Date:  2008-12-01

3.  Maternal HLA class II compatibility in men with systemic lupus erythematosus.

Authors:  Anne M Stevens; Betty P Tsao; Bevra H Hahn; Katherine Guthrie; Nathalie C Lambert; Allison J Porter; Tracy S Tylee; J Lee Nelson
Journal:  Arthritis Rheum       Date:  2005-09

Review 4.  Fetal microchimerism as an explanation of disease.

Authors:  Laura Fugazzola; Valentina Cirello; Paolo Beck-Peccoz
Journal:  Nat Rev Endocrinol       Date:  2010-12-21       Impact factor: 43.330

Review 5.  Naturally acquired microchimerism.

Authors:  Hilary S Gammill; J Lee Nelson
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

Review 6.  Microchimerism in children with rheumatic disorders: what does it mean?

Authors:  Ann M Reed
Journal:  Curr Rheumatol Rep       Date:  2003-12       Impact factor: 4.592

7.  Chimeric maternal cells with tissue-specific antigen expression and morphology are common in infant tissues.

Authors:  Anne M Stevens; Heidi M Hermes; Meghan M Kiefer; Joe C Rutledge; J Lee Nelson
Journal:  Pediatr Dev Pathol       Date:  2009 Sep-Oct

Review 8.  The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies.

Authors:  Corinna E Weckerle; Timothy B Niewold
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

9.  Correlations of Y chromosome microchimerism with disease activity in patients with SLE: analysis of preliminary data.

Authors:  M Mosca; M Curcio; S Lapi; G Valentini; S D'Angelo; G Rizzo; S Bombardieri
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

Review 10.  Why are women predisposed to autoimmune rheumatic diseases?

Authors:  Jacqueline E Oliver; Alan J Silman
Journal:  Arthritis Res Ther       Date:  2009-10-26       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.